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Abstract
Background: Non-suicidal self-injury (NSSI) is a clinically significant behavior affecting approximately 18% of adolescents
and young adults worldwide. The importance of NSSI is supported by its association with a broad spectrum of mental
disorders. Despite its high relevance, evidence-based, specific, time-, and cost-effective treatment approaches are scarce.
Cognitive behavioral therapy (CBT) seems effective in reducing the frequency of NSSI in adolescents and young adults.
However, young people are often reluctant to seek professional help and effective interventions adressing NSSI are not
sufficiently available across all regions of Germany. Research indicates that the majority of youth with risk behavior
(including NSSI) prefer technology-based interventions. To date, effective interventions for adolescents and young adults
with NSSI that are deliverd online are not available.
Methods: The present project aims to develop and evaluate an online intervention for adolescents and young adults
with NSSI based on the content of a recently evaluated face-to-face short-term program that includes elements of CBT
and dialectical behavior therapy (DBT): “The Cutting Down Programme” (CDP). The efficacy of the new online CDP
intervention will be tested in a randomized controlled trial (RCT) in which n = 700 youths engaging in repetitive NSSI will
participate in either an online psychoeducation (n = 350) or online CDP (n = 350). Within a postline assessment four
months after baseline (end of treatment; T1), and follow-up evaluations 12 and 18months after baseline (follow-ups; T2
and T3), NSSI and comorbid symptoms as well as quality of life will be assessed. It is hypothesized that participants
receiving online CDP report a greater reduction in the frequency of NSSI within the last threemonths at T2 (primary
endpoint) compared to those receiving online psychoeducation. Exploratory analyses will focus on predictors of
treatment outcome.
Discussion: We report on the development and evaluation of an online intervention for adolescents and young adults
engaging in NSSI based on the CDP. If supported by empirical evidence, an online-based intervention for NSSI might
help to overcome the limited availability of adequate interventions for youth.
Trial registration: German Clinical Trials Register, DRKS00014623. Registered on 22 May 2018.
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Background
Non-suicidal self-injury (NSSI) affects approximately
17–18% of adolescents worldwide [1, 2]. NSSI is charac-
terized by the intentional and self-inflicted destruction of
body tissue without suicidal intent [3]. The importance of
NSSI is highlighted by recent research illustrating that
NSSI is an important predictor of suicidal behavior [4–6].
Furthermore, it is highly associated with other risk-
behaviors and comorbid psychopathology [7, 8]. NSSI is a
common and highly recurrent behavior that peaks in
adolescence [4, 9–11].
It is essential to develop interventions supporting adoles-
cents with NSSI to stop the behavior. However, only few
interventions have been developed that specifically target
NSSI despite its high clinical pertinence [12–14]. NSSI,
particularly in the context of (emerging) borderline person-
ality disorder (BPD), is often treated with Dialectical Be-
havior Therapy for adolescents (DBT-A), which has shown
to be effective [15]. Other treatments that seem effective
for reducing NSSI frequency are Mentalization-Based
Treatment for adolescents (MBT-A) as well as Cognitive
Behavioral Therapy (CBT) [16, 17]. A recent meta-analysis
[16] suggested that DBT, MBT, and CBT may all be effec-
tive for treating NSSI. However, comprehensive access to
these treatments is restricted due to limited resources and
a lack of specially trained clinicians [18]. Given the limited
resources in the mental healthcare field, it remains a matter
of discussion if DBT-A and MBT-A, which are targeted at
youth with BPD need to be fully implied.
Thus, less intensive yet effective programs that focus
specifically on NSSI are needed to improve the general
standard of care for affected individuals [19], particularly
for adolescents reluctant to seek professional help despite
their actual need. Indeed, help-seeking in adolescents
engaging in NSSI is considerably low [20–22]. Adolescents
endorsing NSSI express more negative attitudes towards
help-seeking compared to past self-injurers and ado-
lescents with no history of NSSI [22]. Negative attitudes
towards help-seeking in adolescents and young adults
with NSSI frequently arise from the disclosure and related
stigma of the behavior towards parents, peers, and mental
health professionals [23]. Typically, adolescents engaging
in NSSI turn to the Internet in order to find peer support
[24]. Although such exchange may actually foster NSSI, by
reinforcement through the sharing of stories and strategies
of NSSI [25], it also offers opportunities for therapeutic
interventions [26]. Studies [27, 28] have shown that a
significant percentage of adolescents and young adults
(45–93%) with risk behavior (including NSSI) prefer a
technology-based intervention format (versus an in-person
face-to-face intervention). Such youth-adequate delivery of
a NSSI intervention may lower barriers towards care and
reach adolescents and young adults in rural areas, where
adequate help is not sufficiently available. To date, the
access to effective intervention requires great efforts and
waiting times, especially for adolescents and young adults
in rural regions. We have previously shown that the time
that adolescents need to travel to receive professional help
for their mental health problems hinders actual help-
seeking behavior [29]. Online-based interventions could
overcome these barriers.
However, to date, no effective online-based intervention
for adolescents engaging in NSSI exists. Time- and cost-
effective brief interventions exclusively targeting NSSI are
rare. Therefore, we have developed an online intervention
for adolescents and young adults with NSSI based on the
content and our experience with a cognitive-behavioral
short-term program for adolescents engaging in NSSI. In
1999, a short-term psychotherapy was developed for
adults exhibiting deliberate self-harm, the manual-assisted
cognitive-behavior therapy (MACT) [30]. In 2011, the
MACT was adapted for adolescents within “The Cutting
Down Programme” (CDP) [31], consisting of 8–12 ses-
sions. Our group has just completed the first randomized
controlled trial (RCT) on the effectiveness of face-to-face
CDP [19] including n = 74 adolescents engaging in NSSI.
Findings are promising and are currently under review.
To deliver such effective interventions online may in-
crease the availability and offer the opportunity to provide
adolescents and young adults concerned with adequate
intervention [32]. Concerning the low help-seeking be-
havior within the particular target group, the low threshold
access, low stigma, and high confidentiality offered by on-
line interventions are promising in reducing the treatment
gap. Consequently, our proposed online intervention could
lower barriers for a high-risk target group to seek pro-
fessional help.
Objectives and outcomes
The main objective of the present study is to evaluate a
newly developed, easily accessible, online intervention pro-
gram for adolescents and young adults engaging in NSSI,
based on an existing short-term face-to-face manualized
intervention (CDP). The effectiveness of online CDP will be
evaluated in a RCT in comparison to an online psychoedu-
cation program. The main outcome of the trial is the reduc-
tion in the frequency of NSSI within the last threemonths
assessed by the NSSI Severity Questionnaire (NSSV-SG)
[33] at one-year follow-up (primary endpoint; T2).
Secondary outcome criteria are health-realted quality
of life as well as comorbid psychopathology and suicidal
behavior.
Primary hypothesis
Participants receiving online CDP will show a signifi-
cantly greater reduction in the frequency of NSSI within
the past three months at T2 compared to participants
within the online psychoeducation group.
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Methods/Design
Setting and recruitment
The present trial is a study within the consortium “Self-in-
jury-Treatment: Assessment, Recovery (STAR).” Coopera-
ting study sites (Ulm, Landau, Mannheim, Karlsruhe, and
Berlin) will investigate the natural course of NSSI as
well as psychocological and neurobiological predictors
and improve ways to dessiminate specific knowledge
on NSSI to primary caregivers.
We aim to include n = 700 adolescents and young adults
aged 15–21 years in the trial. They will be randomly
assigned to either receive the online CDP or online psy-
choeducation only. Participants in both groups will be
assessed at the beginning (baseline; T0), 4 (post-line; T1),
12, and 18months after the initial baseline assessment
(follow-up; T2, T3) in order to evaluate treatment effects.
The flowchart of the trial is shown in Fig. 1. The schedule
of this trial is shown in Fig. 2 (Additional file 1).
Recruitment is conducted online through social
media (such as Instagram and Facebook), websites,
and online forums. Furthermore, flyers will be printed
and disseminated at the clinical centers participating in
the study (Berlin/Neuruppin, Heidelberg, Landau,
Mannheim, Ulm). All eligible participants registering
on the central project website will be offered to participate
in the online intervention.
Inclusion and exclusion criteria
Based on the criterion A of the NSSI disorder provided
in the Diagnostic and Statistical Manual of Mental
Disorders (DSM), fifth edition, section three [3], eligible
participants are required to have engaged in NSSI on at
least five days during the last 12 months. Eligible partici-
pants are aged 15–21 years. Furthermore, all participants
need to provide informed consent online by clicking a
checkbox. Participants will be excluded if they are
currently receiving individual psychotherapy (inpatient
and outpatient).
Procedure and randomization
Before inclusion, participants will be provided with
written information on the study’s background, aims
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) 2010 flow diagram
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and procedures, the online CDP and online psycho-
education, randomization, the advantages and risks of
participating, data collection and data safety regulations,
as well as voluntary participation.
Informed consent will be obtained after an initial
screening phase within T0 to check for eligibility and
before registering on the study website. Participants
confirm by ticking a box on the website that they have
read and understood the provided information and that
they are willing to participate.
Within the self-report assessment and on the study
platform, participants will be informed that there is no
immediate check of the data they enter and thus no
immediate measures can be guaranteed in case a partici-
pant reports acute suicidality. Participants will be made
aware of emergency numbers in case of acute suicidality.
After providing informed consent, participants have to
provide an email address as well as a username in order
to register for the study. An activation link will be sent
to the email address provided. Once the address has
been verified, a unique code will be generated and
assigned to the participant, in order to enable the
matching of follow-up assessments.
After consent and registration to the platform, all
eligible participants will be asked to complete a 45-min
assessment within T0. After completion of the assessment
at T0, participants will be randomized to the online CDP
or the online psychoeducation and will be invited to par-
ticipate in assessments at T1, T2, and T3. To promote
participant retention, participants will be reminded to
participate in the assessments via standardized e-mails at
each point in time. Within a first e-mail, participants re-
ceive an invitation as well as a link to the assessment.
After 3 and 14 days, participants receive reminder e-mails
for the assessment. This applies to every assessment point.
To prevent bias, participants will be randomly assigned
to receive either the online psychoeducation or the online
CDP using block randomization (50/50). Participants will
be randomized based on their study ID. Enrolment,
generation of allocation sequence, and assignment of
participants take place online and are therefore
computer-based. Participants will be informed about
their group affiliation by automatic message that pops
up immediately after randomization. Blinding is not
completely possible. Participants cannot be blinded
due to the different nature of the interventions. Blinding
Fig. 2 SPIRIT figure: Schedule of enrollment, interventions, and assessments
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of the researchers is not possible, because participants in
the online CDP group receive case-management and
personal chats as well as telephone calls.
Data assessment
All assessments will be conducted online. Thus, self-
report questionnaires will be used in this trial. The assess-
ment at T0 takes place before randomization and the
subsequent start of treatment. All assessment measures
are conducted at every time point (T0, T1, T2, T3), except
the evaluation of the online CDP, which only takes place
at T1. Within a first screening phase of T0, participants
are checked for eligibility. All eligible participants are
invited to participate in the trial. Those not eligible for the
trial because of current individual psychotherapy and/or
too low frequency of NSSI are invited to participate in a
separate non-interventional observational study.
Assessment measures
T0 comprises sociodemographic questions, which will
gather information about gender, nationality, state of
adolescents’ and parents’ education, and current living
situation.
For detailed assessment of NSSI severity, we use the
NSSV-SG [33], assessing the frequency and nature of
NSSI within the past three months using 60 items. The
evaluation of the psychometric properties in a clinical
and an online sample of adolescents and young adults
indicates high internal consistency (Cronbach α = 0.73),
a test–retest reliability of 0.77 (n = 29; interval: six
weeks), and supports the validity of the questionnaire
[34]. The KIDSCREEN-10 will be used to assess general
health-related quality of life (HRQoL) in participants
[35]. It consists of 10 items and was developed across
Europe for use in children aged 8–18 years and is a valid
instrument with acceptable retest reliability [35]. Internal
consistency was high (Cronbach α = 0.81) [36]. To assess
emotional and behavioral difficulties in children and ad-
olescents, the Strengths and Difficulties Questionnaire
(SDQ) [37] with 25 items will be used. A study, evalua-
ting the validity of the German version of the SDQ, indi-
cates that the SDQ is valid for most clinical and research
purposes [38]. In addition, the questionnaire shows good
internal consistency (Cronbach α = 0.81) [39]. The Bor-
derline Symptom List-23 (BSL-23) [40] is a quantitative
assessment of borderline-specific symptoms based on
DSM-IV criteria [41]. It consists of 23 items and shows
high internal consistency (Cronbach α = 0.94) [40]. The
BSL-23 is a reliable and valid instrument to assess
borderline-specific symptoms [40]. To assess personality
disorders, the Self-report Standardised Assessment of
Personality – abbreviated scale (SAPAS-SF) consisting of
eight items [42] will be used. The SAPAS is a valid and
reliable instrument to screen for personality disorders
[42, 43]. The internal consistency coefficients were
rather low, in the range of 0.35–0.51 [44]. The Paykel
Suicide Scale (PSS) [45] assesses the intensity of suicidal
behaviors by level of intent and consists of five items.
The Patient Health Questionnaire-9 for Adolescents
(PHQ-A) [46] is a modified version of the Patient Health
Questionnaire-9 (PHQ-9) [47]. The PHQ-9 measures de-
pression severity and shows good internal consistency
(Cronbach α = 0.84) [48]. The PHQ-A consists of nine
items based on DSM-IV [41]. The PHQ-A is a reliable
and valid measure of depression severity [46] and
shows good.
Beyond that, additional items will be presented to eva-
luate the online CDP. Within 20 items, participants will
rate how helpful the different sessions have been and what
they have learned on a 5- and 6-point Likert Scale, re-
spectively. Furthermore, the revised short form of the
Working Alliance Inventory (WAI-SR) [49] consisting of
12 items was used to assess the therapeutic relationship.
Internal consistency was excellent (Cronbach α > 0.90)
[50]. Finally, a modified version of The Fragebogen
zur Patientenzufriedenheit (ZUF-8; Patient Satisfaction
Questionnaire) was used to assess treatment satis-
faction. It consists of eight statements, which are
answered on a 4-point scale ranging from ‘very satis-
fied’ to ‘quite dissatisfied’ [51].
Participants’ incentive
Participants receive no direct financial compensation for
participating in the study. However, they are informed
about the chance to win a gift voucher (€50) for their
participation. After completion of T1 assessment, parti-
cipants have the chance to win the voucher.
Interventions
N = 700 participants will be randomized to one of the
two possible treatment conditions (online CDP versus
online psychoeducation). Table 1 provides an overview
of the interventions in both groups. The platform is
available for four months for each participant after
randomization. After a successful evaluation of the
online CDP, the intervention could be disseminated to
provide all individuals concerned with access to the
online CDP. However, there are no plans concerning an
immediate access to the intervention for the control
group after conclusion of the trial.
Online psychoeducation
The online psychoeducation provides static psycho-
educative content on the causes, consequences, and
concomitants of NSSI. This module is available for both
groups. Recommendations concerning the intensity of
use are rather individual depending on the already
existing knowledge on NSSI. Thus, the intensity of use
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is determined by the participant and tracked as a
variable of interest.
Online CDP
The online CDP group is offered an add-on online inter-
vention. The face-to-face, short-term intervention is
based on elements of CBT and DBT and is specifically
tailored for the treatment of NSSI in adolescents. The
treatment length is 8–12 sessions. The treatment con-
sists of four modules that can be expanded by optional
exercises. Module 1 focuses on providing knowledge
about CBT and NSSI as well as promoting therapy
motivation. The focus of module 2 is on identifying the
reasons for the NSSI. In module 3, the patients are
encouraged to test alternative behaviors to NSSI and
module 4 comprises the stabilization of the alternative
behaviors. The content of the intervention is structured
in a manual for participants and a separate manual for
therapists that is feasible for translation into an online
intervention. The modules in the manual have all been
developed based on a comprehensive literature review
on NSSI including associated psychological phenomena.
Within the online CDP, the intervention is delivered via
personal chat or telephone calls with the case managers
and assisted by automatic content of the web-based plat-
form, which provides 10 different sessions. The sessions
comprise content of the face-to-face manual adapted for
online use. In addition to text, participants are provided
with exercises and quizzes to deepen their theoretical
knowledge on the one hand and to ensure under-
standing of the provided content on the other hand. In
addition, videos of two fictitious patients are provided in
every session. These fictitious patients present common
problems and how they deal with them. The online CDP
group will further have access to a moderated online
group chat facilitating exchange with other participants
and providing peer support. Additionally, all participants
in the online CDP group are monitored for NSSI and
the use of skills on a weekly basis to receive an indivi-
dual feedback on their progress. The intervention will
solely be provided over the Internet.
Participants are encouraged to use the online CDP as
often as they want to. There is no restriction or speci-
fication concerning the intensity of use. Again, the use
of the online CDP is determined by the individual.
Individual contacts with the case managers via personal
chat or telephone call are regularly offered once a week.
However, further appointments are possible if particular
circumstances require additional support. Group chats
also take place once a week.
All participants are permitted to seek treatment
outside of the clinical trial if necessary. The nature
and frequency/dose of interventions outside of the
trial will be assessed using structured questionnaires.
Emergency procedure
If participants within the online CDP group indicate
serious suicide thoughts within a chat or telephone call
with a case manager, suicidality is clarified by the
respective case manager in a first step, as well as by the
responsible psychiatrist, as needed. Participants will then
be referred to emergency numbers.
There are no general discontinuation criteria for
the trial.
Staff
All case managers are clinical psychologists who receive a
priori training in the online CDP intervention. Further-
more, case managers will receive weekly supervision by a
specifically trained clinical psychologist with a clinical
background in CBT and DBT to ensure the quality of
treatment. In addition, monthly external supervision will
be offered by a specifically trained psychotherapist in CBT
and DBT. Beyond that, psychiatrists both for children and
adolescents as well as for adults who also receive a priori
Table 1 Overview of interventions
Group affiliation Intervention
Both groups Online psychoeducation:
- basic facts on NSSI, NSSI and emotions, NSSI
and development, treatment for NSSI in terms
of plain information
- static content
- dose of the psychoeducative intervention
is determined by the user
- access for four months
Control group Online psychoeducation
Intervention group Online psychoeducation
Monitoring module:
- weekly assessments on NSSI and the use
of skills for individual feedback
Add-on online CDP:
- access to 10 different sessions: (1) identifying
resons for NSSI, getting to know skills;
(2) promoting motivation; (3) getting to
know and dealing with feelings;
(4) establishing positive activities;
(5) understanding the links between
thoughts, feelings, and behaviors and
learning how to find a more helpful way
of thinking; (6) identifying core beliefs and
rules of living; (7) identifying coping
strategies; (8) promoting assertiveness;
(9) identifying strategies and skills that are
based on the concepts of mindfulness and
distress tolerance; (10) exploring triggers
for NSSI, reviewing coping strategies
- techniques: chat and telephone calls
with case managers, moderated group
chat, exercises, videos, quizzes
- access for four months
Kaess et al. Trials          (2019) 20:425 Page 6 of 10
training in the online CDP are available in cases of
emergency. All case managers are based in Heidelberg.
Sample size
Power analysis was based on reported effect sizes of CBT
in the reduction of NSSI, drawing on the most extensive
meta-analysis in the field [52] reporting a main effect for
the reduction of NSSI in n = 8/14 studies; g = − 0.27, 95%
CI [− 0.17, 0.38], z = 4.96, p = 0.001). Most studies
included in the analysis used a treatment as usual (TAU)
control group design. Comparing online CDP against an
online psychoeducation we expect similar effects. Power
analysis was calculated for F-statistics using an alpha-error
probability of 0.05. The estimation model was based on a
mixed effect linear regression with main effects (repeated
measures and group) and their interaction. We consid-
ered covariates with potential impact on the outcome
(sex, age). Based on the calculation, a minimum sample
size of n = 344 is necessary to reveal significant effects
at a critical F-value of F = 1.859. Based on this esti-
mation, the study would allow for up to 51% drop-out
and still be sufficiently powered revealing effects in a
completer analysis.
Statistical analysis
The primary hypothesis will be addressed using a mixed
linear regression analysis with robust variance estimation,
assessing the frequency of NSSI within the past 3months
at T0 and T2. We will consider main and interaction
effects of the two main effects: (1) group allocation; and
(2) time of assessment within repeated measures. The
individuals’ ID will be used as random effect variable. In
secondary analyses, potential sociodemographic and cli-
nical mediators and predictors of intervention response
will be investigated. Missing data and individuals with-
drawn from the trial will be handled using an intention-
to-treat (ITT) approach. All participants randomized will
be considered in the analyses. In the case of drop-outs or
missing data, we will use a last-value-carried-forward
imputation method, assuming that those who dropped
out of the intervention showed no improvement in NSSI
relative to baseline.
Data safety
The confidentiality of research participants is secured
by providing unique study identifiers unrelated to the
real name.
The Coordination Centre for Clinical Trials (KKS) in
Heidelberg is involved in preparing the investigator site
file. Due to the online-based nature of the intervention,
classical site visits are not necessary. Instead, pre-trial
visits in terms of profound explanation of online content
and all aspects related to delivery of the intervention
took place. In addition, an independent data safety and
monitoring board (DSMB) was established to monitor
the collection and analyses of data.
Computerized assessments guarantee the highest level
of data integrity and quality, i.e. missing data will be
minimized and false data entry will be prevented. Online
access allows for continuous monitoring of data collec-
tion, documentation of access logs, and traceability of all
entered data (user and timestamp) as well as restoration
of all previous states. A Distributed Replicated Block
Device (DRBD)-based cluster will provide synchronous
replication of all data during data entry on two separate
servers and highest availability. In addition, full and
incremental backups will be conducted following a
predefined back-up plan. Data storage and transfer
will be encrypted. Access to the data will be strictly
limited to authorized persons and will be password-
protected. All servers are located at the University
Hospital Heidelberg.
Harms
In view of the non-invasive intervention, the risk for
participants is considered marginal. Irrespective of the
individual allocation to one of the treatment arms, par-
ticipating adolescents and young adults benefit from
receiving psychoeducation on NSSI and associated men-
tal distress. Adolescents will be instructed on the crisis
procedures mentioned above. There is no obvious risk
for participants. The independent KSS Heidelberg will
provide expert advice and monitoring regarding all
aspects of safety. Beyond that, the DSMB will be in-
formed about adverse events, such as suicidal acts.
Ethical issues and dissemination
The study will be conducted in accordance to the declar-
ation of Helsinki and the rules for physicians of the medical
association (“Landesärztekammer”) of Baden-Württemberg
in their currently valid version. Study participation is volun-
tary. Consent can be withdrawn at any time without stating
the reason and without any individual disadvantage for
subsequent medical care. All participants will need to con-
sent electronically to the terms of the study. In case of
study withdrawal, previously collected data will be
destroyed if desired unless data are already included in ana-
lyses. A waiver for parental consent was obtained from the
institutional review board of the medical faculty at the Uni-
versity of Heidelberg. Ethics committees are able to waive
paternal informed consent if studies are expected to result
in great benefits for a specific target group or if studies
could not be conducted otherwise [53]. Both points apply
to the present study. Beyond that, the study is a non-
invasive low-risk study and within the medical community,
the age of 14 is considered to be the age when minor par-
ticipants are able to consent to participation in low-risk
studies [54, 55]. Cognitive abilities are comparable to those
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in adults at the age of 14 years [56]. Furthermore, the study
is about reducing obstacles in receiving professional help.
Thus, asking for parental informed consent would increase
hurdles, especially for adolescents who are often struggling
to receive adequate professional help [57].
The study protocol has been approved by the ethics
committee in Heidelberg for consulting of professional
conduct before the start of our study.
In the case of relevant protocol modifications, the
institutional review board of the medical faculty at the
University of Heidelberg will be informed and an amend-
ment will be submitted. Furthermore, information within
the German Clinical Trials Register will be updated to
inform the public about possible changes.
All confidential information is subject to medical con-
fidentiality and to the requirements of the European,
Federal and State Data Protection Act (Europäische
Datenschutzgrundverordnung, EU-DSGVO, Bundesda-
tenschutzgesetz, BDSG and Landesdatenschutzgesetz,
LDSG). The data will be stored and processed in a
pseudonymized manner. No third parties will gain in-
sights into the original data.
Beyond regular journal publication, general strategies
are planned to disseminate trial results: coordination and
participation in scientific meetings (scientific disse-
mination) as well as dissemination of materials created in
the subproject STAR-TRAIN, which develops practical in-
structions for the contact to adolescents and young adults
with NSSI in primary care practice (dissemination to the
public). The use of professional writers is not intended.
Access to the protocol is ensured through the registration
and regular update of the trial in the German Clinical
Trials Register (STAR: Self-Injury: Treatment, Assess-
ment, Recovery - Online Intervention for Adolescent
Nonsuicidal Self-Injury - A randomized controlled trial;
http://www.drks.de; DRKS00014623; registration date:
22 May 2018).
Discussion
NSSI is a significant problem in adolescents and young
adults, associated with severe psychopathological distress
and potential long-term consequences [4–7]. Available
intervention options are limited in their outreach and
often fail to reach youth in rural areas and those with
low help-seeking behavior. An online intervention may
help to overcome existing barriers and improve general
access to care for adolescents and young adults engaging
in NSSI. However, so far, no study has addressed the
effectiveness of online interventions for this target
group. Thus, this is the first RCT to develop and eva-
luate an Internet-based short-term treatment for NSSI
in adolescence and young adulthood. The present study
and related intervention make several advances in the
treatment of NSSI and build upon previous work in
innovative ways.
First, we focus on NSSI, which is a significant issue in
the mentioned age group. Second, we provide an eva-
luated short-term program addressing NSSI specifically.
Third, we use an Internet-based approach to deliver
therapy content. Intervening via this medium offers a
number of advantages over face-to-face interventions and
promises to reach a significant number of affected indivi-
duals regardless of their place of residence. In addition,
help-seeking is considerably low in the target group and
online interventions may lower barriers for young people
to seek help.
Limitations
Despite the mentioned advantages, potential limitations of
the study design should be acknowledged. Participant
drop-out is a potential challenge, particularly given the
online nature of the intervention. Based on a Cochrane
Review [58], attrition rates from 4% [59] up to 21% [60]
were reported within face-to-face treatments of adolescent
self-harm (including NSSI). Concerning online interven-
tions for adolescents with diagnoses of depression [61, 62]
and anxiety [61, 63], drop-out rates from 6% [64] up to
31% [65] were reported. Considering the mentioned
studies, an attrition rate of 30% to T1 and 50% to T2
is expected, expecting n = 504 adolescents to complete
the intervention. The study is suitably powered even
down to a completer sample of n = 344 adolescents.
Another potential limitation is that all participants will
be able to access alternative treatments outside of the trial.
Information will be collected from participants about
menthal health service usage and the potential impact of
this on outcomes will be statistically controlled for.
In addition, we are not able to diagnose mental dis-
orders because of the exclusive use of surveys. This is
due to the online character of the study.
The provision of an online intervention, tailored to the
needs of adolescents and young adults, may provide an
easily accessible, cost-effective, and flexible medium for
improving mental health outcomes for affected individuals.
Trial status
Protocol version 1.0, 25 April 2018.
The trial is scheduled to be completed by 31 October
2021. Recruitment began on 1 November 2018 and
recruitment will be completed approximately by 31
October 2020.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents*. (DOC 123 kb)
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